DelveInsight's 'Antibody-drug Conjugates in Oncology Competitive Landscape – 2024' report provides comprehensive global coverage of ...

The following is a summary of “Altered B-cell, plasma cell and antibody immune profiles in blood of systemic mastocytosis,” ...

Amgen (NASDAQ:AMGN) today announced the presentation of positive top-line results from the Phase 3 MINT trial evaluating the ...

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding ... high-resolution cryo-EM structure of human IgM complexed with CD5L to reveal their ...

This useful study reports that the exogenous expression of the microRNA miR-195 can partially compensate in early B cell development for the loss of EBF1, one of the key transcription factors in B ...

Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts. Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General ...

IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.

IGM Biosciences Inc.’s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company’s pivot away from ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Doctors suggested putting Emily on a clinical trial for CAR T-cell therapy, an experimental treatment that had just been approved for paediatric patients by the US Food and Drug Administration.

Iced coffee fans are always looking for the perfect glass to enjoy their beverages. Now, B&M is selling the "perfect" option, but it comes with a warning from other shoppers. The Natural Home ...